£12.5M
The seed round was led by BGF with participation from F-Prime Capital, Kindred Capital, and Jonathan Milner.
"Our technology is addressing the current limitations of cellular reprogramming for treatment of age-related illnesses, "
Funding Announcements
Filter
Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
308
Total raised
£4.1B
disclosed amounts
This month
£27.8M
raised so far
£3.5M
.png)
The latest investment brings total equity financing to £7.2m and will support clinical progression of internal assets.
"A third of all FDA-approved drugs target GPCRs, yet, despite decades of research and billions of funding, only a few GPCR-targeting antibodies exist. Thanks to the support of our investors, we are one step closer to making GPCRs and other challenging targets druggable, bringing needed therapies to patients across the globe."
i&i Biotech Fund + 5 others
£45.9M
Singular led the Series B round, which will help fund data collection and foundational model development.
"We are pushing past AI’s limits in biological design by doubling down on solving the fundamental data gap that the entire biotech industry faces, Basecamp Research is using its technology to generate new and deeper insights, going beyond known biology and each day expand what we can offer to our partners in the biopharma ecosystem."
£550K
The seed round was backed by British Design Fund to support the development of novel wound care devices.
"Around the world, wounds are still being treated largely the same way as they were 150 years ago, with dressings that are often not fit for purpose, leading to a slow, painful treatment process and poor outcomes for patients."
£950K
The funding was led by Mercia Ventures and will support preparations for upcoming clinical trials.
